Patents by Inventor Kevin Kayser

Kevin Kayser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210238222
    Abstract: Processes for producing recombinant proteins having low levels of residual host cell proteins. The processes comprise utilizing engineered host cell lines in which specific host cell proteins are tagged with purification tags, wherein the purification tags can be used to remove those specific host cell proteins from the recombinant proteins.
    Type: Application
    Filed: May 3, 2019
    Publication date: August 5, 2021
    Inventors: Trissa Borgschulte, Joaquina Mascarenhas, Martin Zillmann, Frank Swartzwelder, Kevin Kayser
  • Publication number: 20210238628
    Abstract: Mammalian cell lines genetically engineered to have reduced or eliminated expression of specific host cell proteins, and methods for using the engineered mammalian cell lines for the production of recombinant proteins having low levels of residual host cell protein contamination.
    Type: Application
    Filed: May 3, 2019
    Publication date: August 5, 2021
    Inventors: Joaquina Mascarenhas, Trissa Borgschulte, Kevin Kayser
  • Patent number: 10377990
    Abstract: The present invention provides mammalian cell lines that have been genetically engineered causing such cell lines to be resistant to viral entry and/or propagation, and provides methods of using said cell lines to reduce or prevent viral contamination of biologic production systems.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: August 13, 2019
    Assignee: SIgma-Aldrich Co. LLC
    Inventors: Nan Lin, Joaquina Mascarenhas, Audrey Chang, David Onions, Henry George, Kevin Kayser
  • Patent number: 9670271
    Abstract: The present invention provides cell lines deficient in mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I (Mgat1). Also provided are methods for producing the Mga1 deficient cell lines and methods for using the Mgat1 deficient cell lines for the production of recombinant proteins having simple glycoforms.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: June 6, 2017
    Assignee: SIGMA-ALDRICH CO. LLC
    Inventors: Nan Lin, Natalie Sealover, Henry George, Kevin Kayser
  • Publication number: 20160369240
    Abstract: The present invention provides mammalian cell lines that have been genetically engineered causing such cell lines to be resistant to viral entry and/or propagation, and provides methods of using said cell lines to reduce or prevent viral contamination of biologic production systems.
    Type: Application
    Filed: March 3, 2015
    Publication date: December 22, 2016
    Inventors: Nan LIN, Joaquina MASCARENHAS, Audrey CHANG, David ONIONS, Henry GEORGE, Kevin KAYSER
  • Publication number: 20160272696
    Abstract: The present invention provides cell lines deficient in mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I (Mgat1). Also provided are methods for producing the Mga1 deficient cell lines and methods for using the Mgat1 deficient cell lines for the production of recombinant proteins having simple glycoforms.
    Type: Application
    Filed: June 2, 2016
    Publication date: September 22, 2016
    Inventors: Nan LIN, Natalie SEALOVER, Henry GEORGE, Kevin KAYSER
  • Patent number: 9376484
    Abstract: The present invention provides cell lines deficient in mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I (Mgat1). Also provided are methods for producing the Mga1 deficient cell lines and methods for using the Mgat1 deficient cell lines for the production of recombinant proteins having simple glycoforms.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: June 28, 2016
    Assignee: SIGMA-ALDRICH CO. LLC
    Inventors: Nan Lin, Natalie Sealover, Henry George, Kevin Kayser
  • Publication number: 20160145645
    Abstract: The present disclosure encompasses an isolated cell comprising an exogenous nucleic acid sequence located within or proximal to a predetermined genomic locus, wherein the exogenous nucleic acid sequence comprises at least one recognition sequence which can be exploited by one or more polynucleotide modification enzymes for targeted integration of a recombinant protein. The disclosure further provides methods for preparing such cells, and methods for retargeting such cells for the production of recombinant proteins, and kits for the same.
    Type: Application
    Filed: June 19, 2014
    Publication date: May 26, 2016
    Applicant: Sigma-Aldrich Co. LLC
    Inventors: Scott BAHR, Trissa BORGSCHULTE, Kevin KAYSER
  • Publication number: 20140349341
    Abstract: The present invention provides cell lines deficient in mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I (Mgat1). Also provided are methods for producing the Mga1 deficient cell lines and methods for using the Mgat1 deficient cell lines for the production of recombinant proteins having simple glycoforms.
    Type: Application
    Filed: January 10, 2013
    Publication date: November 27, 2014
    Applicant: SIGMA-ALDRICH CO. LLC
    Inventors: Nan Lin, Natalie Sealover, Henry George, Kevin Kayser
  • Patent number: 7919322
    Abstract: The present invention provides methods, nucleic acid constructs, and kits for selectively deleting a region of a nucleic acid sequence. Specifically, it utilizes retargeting retroelements to place site-specific recombination sites at targeted locations in the nucleic acid sequence. The region between the recombination sites is then deleted using a site-specific recombination system.
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: April 5, 2011
    Assignee: Sigma-Aldrich Co.
    Inventors: Melissa Spears, Greg Davis, Kevin Kayser
  • Publication number: 20080044883
    Abstract: The invention provides an Enzyme Blend comprising a DNA polymerase and a DNA repair enzyme. Methods and kits for amplification of DNA that is damaged, undamaged, or suspected of being damaged are also provided.
    Type: Application
    Filed: June 15, 2007
    Publication date: February 21, 2008
    Applicant: SIGMA ALDRICH CO.
    Inventors: Chistopher Walker, Ernest Mueller, Kevin Kayser, Jason Milligan, Erik Eastlund
  • Publication number: 20070231865
    Abstract: The present invention provides methods, nucleic acid constructs, and kits for selectively deleting a region of a nucleic acid sequence. Specifically, it utilizes retargeting retroelements to place site-specific recombination sites at targeted locations in the nucleic acid sequence. The region between the recombination sites is then deleted using a site-specific recombination system.
    Type: Application
    Filed: March 29, 2006
    Publication date: October 4, 2007
    Inventors: Melissa Spears, Greg Davis, Kevin Kayser
  • Publication number: 20050026147
    Abstract: The invention provides an Enzyme Blend comprising a DNA polymerase and a DNA repair enzyme. Methods and kits for amplification of DNA that is damaged, undamaged, or suspected of being damaged are also provided.
    Type: Application
    Filed: July 29, 2003
    Publication date: February 3, 2005
    Inventors: Christopher Walker, Ernest Mueller, Kevin Kayser, Jason Milligan, Erik Eastlund
  • Patent number: 5955350
    Abstract: A process for remediation of contaminated solid materials comprising polynuclear aromatic hydrocarbon contaminated solid materials, polychlorinated hydrocarbon contaminated materials, and mixtures thereof by sequential biological/chemical/biological treatment in which the contaminated solid materials are biodigested under suitable conditions by a first aerobic or anaerobic digestion, producing a first biodigestion product. The first biodigestion product is then contacted for chemical treatment with hydrogen peroxide in the presence of ferrous ion in amounts and under conditions suitable for chemical oxidation, forming a mixture and oxidizing the first biodigestion product, producing biodegradable hydrocarbon product materials having enhanced biodegradability. The product materials are then biodigested under suitable conditions by a second aerobic or anaerobic digestion.
    Type: Grant
    Filed: February 13, 1997
    Date of Patent: September 21, 1999
    Assignee: Institute of Gas Technology
    Inventors: Bhupendra K. Soni, Kevin Kayser, Robert L. Kelley, Vipul J. Srivastava